EPISODE · Dec 5, 2022 · 56 MIN
Eye Believe 2022: D2T1 ”Your Eye After Treatment”
from The Eye Believe Podcast · host A Cure In Sight
Join Dr. David Reichstein of Tennessee Retina to discuss what to expect in your eye after treatment. Dr. Reichstein is a graduate of the world's premier Ocular Oncology Fellowship at Wills Eye Hospital, under the direction of Drs. Jerry and Carol Shields. Dr. Reichstein's interests include the diagnosis and management of patients with all types of ophthalmic tumors, including uveal melanoma or nevus, retinoblastoma, vitreoretinal and choroidal lymphoma, vascular tumors of the posterior segment, and choroidal metastases. He also has expertise in the management of anterior segment tumors including conjunctival melanoma, conjunctival or corneal intraepithelial neoplasia, and squamous cell carcinomas of the anterior segment. Dr. Reichstein's therapeutic expertise includes the use of topical and systemic chemotherapy, surgical management of ophthalmic tumors, and radiation using brachytherapy or external beam radiation.
Embed this episode
What this episode covers
Join A Cure in Sight for the Eye Believe 2022 Survivorship seminar, hosted in Nashville, TN by Dr. Reichstein with Tennessee Retina. This podcast and this Eye Believe Session are possible because of our presenting sponsor, Castle Biosciences. Thank you to all our sponsors, Immunocore, Delcath, TriSalus, and Aura, Foghorn Therapeutics, and Replimune, without whom this event wouldn’t be possible.
NOW PLAYING
Eye Believe 2022: D2T1 ”Your Eye After Treatment”
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.